ArticleHeliyon2024
Stability and SERS signal strength of laser-generated gold, silver, and bimetallic nanoparticles at different KCl concentrations.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Gold and silver nanoparticles for safe and effective biomedical applications.Discover nano · 2026Review
- Next-Generation SERS Probes: Engineering Hotspots, Intelligent Molecular Targeting, and AI-Driven Spectral Analysis for Emerging Applications.Nanomaterials (Basel, Switzerland) · 2026Review
- A Simple Three-Step Method for the Synthesis of Submicron Gold Particles: The Influence of Laser Irradiation Duration, Pulse Energy, Laser Pulse Duration, and Initial Concentration of Nanoparticles in the Colloid.Nanomaterials (Basel, Switzerland) · 2026Article
- Silver nanoparticles as antimicrobials: A comparative analysis of green and traditional chemistry synthesis methods.PloS one · 2026Article
- Gradient Nanostructures and Machine Learning Synergy for Robust Quantitative Surface-Enhanced Raman Scattering.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Quantifying the distinct role of plasmon enhancement mechanisms in prototypical antenna-reactor photocatalysts.Nature communications · 2025Article
- In Situ Raman Spectroscopy for Early Corrosion Detection in Coated AA2024-T3.Sensors (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Noble metal nanoparticles, specifically gold and silver, are extensively utilized in sensors, catalysts, surface-enhanced Raman scattering (SERS), and optical-electronic components due to their unique localized surface plasmon resonance (LSPR) properties. The production of these nanoparticles involves various methods, but among the environmentally friendly approaches, laser ablation stands out as it eliminates the need for toxic chemicals during purification. However, nanoparticle aggregation poses a challenge in laser ablation, necessitating the addition of extra materials that contaminate the otherwise clean process. In this study, we investigate the effectiveness of a biocompatible material, potassium chloride (KCl), in preventing particle aggregation. Although salt is known to trigger aggregation, we observed that certain concentrations of KCl can slow down this process. Over an eight-week period, we examined the aggregation rate, extinction behavior, and stability of gold, silver, and hybrid nanoparticles generated in different KCl concentrations. Extinction spectra, SEM images, SERS signal strength, and zeta potential were analyzed. Our results demonstrate that laser ablation in water and salt solutions yields nanoparticles with a spherical shape and a negative zeta potential. Importantly, we identified the optimal concentration of potassium chloride salt that maintains solution stability and SERS signal strength. Adsorbed chloride ions on silver nanoparticles were evidenced by low-frequency SERS band near 242 cm
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.